Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Closed
Phase 2/3
This trial is looking at new drugs in combination with cytarabine (Ara C) for acute myeloid leukaemia and high risk myelodysplastic syndrome (MDS).
Recruitment start: 1 December 2011
Recruitment end: 31 December 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mike Dennis
Bloodwise
Cardiff University
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 15 July 2024
CRUK internal database number: 8642
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
